DexCom Inc (BSP:D1EX34)
R$ 9.65 0 (0%) Market Cap: 188.46 Bil Enterprise Value: 189.05 Bil PE Ratio: 47.26 PB Ratio: 15.58 GF Score: 74/100

DexCom Inc at Piper Jaffray Healthcare Conference Transcript

Dec 04, 2019 / 02:30PM GMT
Matthew Oliver O;Brien
Piper Jaffray Companies, Research Division - MD and Senior Research Analyst

' -

Good morning, everybody. Thanks so much for joining us. My name is Matt O'Brien, I cover Medtech here at Piper. Extremely pleased to have the DexCom team here with us. We've got Steve and Sean up here from the company. Thanks for making the trip all the way across the country. Thanks for coming from San Diego to New York. I'm not sure how wise that was, but maybe we're the ones that aren't wise for having it in San Diego.

But for starters, Steve, I wanted to start with you, I've known you a long time. You've been at DexCom a long time. You've worn a million different hats there. What are we not thinking about for DexCom, bigger picture? Everybody wants to talk about pharmacy and all this other stuff near term, but what are we not thinking about going out 3 to 5 years that could be really influential to the business?

Steven R. Pacelli
DexCom, Inc. - EVP of Strategy & Corporate Development

So I appreciate you calling me old, starting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot